Amarin Corp Plc (AMRN)

[Birdbrain Ideas]

Thanks Raf. This is the second consecutive week where scripts are going in a positive direction compared to generics. I recall that happening for a week in the past, but it always seemed to be followed by generics roaring back the following week to dim our hopes.

I don't know what could be causing what I wish to be a trend. Is it some positive ramifications from the Health Net settlement? Could it be because Dr. Bhatt is now in charge of cardiology at a major New York hospital and likely educating scores of doctors there and perhaps elsewhere in New York City to wake up to the benefits of Vascepa?

The one blemish seems to be refills and I have to think that's the fault of pharmacists, teamed with insurance companies, steering refills to generics to benefit from kickbacks or favorable pricing they may receive from the generic companies when they steal prescriptions away from a brand drug. It might be harder for them to insist on a generic when a prescription is first written by a doctor, particularly if it is clear that the prescription is for reasons that would violate the valid Amarin patents. But once refill time arrives, they can probably slip in the generic with deniability in the event they were ever called out on it because there is no additional information from a doctor.